Emami N

ORCID: 0000-0001-9219-8090 · 3 papers in corpus
article 2026
Role of sRAGE in clinical heterogeneity and inflammation in endometriosis patients undergoing IVF; case-control study
BMC endocrine disorders ·doi:10.1186/s12902-026-02416-6

BACKGROUND: Endometriosis is a multifactorial, chronic inflammatory disorder that affects a substantial proportion of women during their reproductive years and is frequently associated with pelvic pain and infertility. Accumulating evidence…

2025
Relation of Follicular Fluid Soluble Receptor for Advanced Glycation End-Products Concentration and Anti Mullerian Hormone in Polycystic Ovary Syndrome and Non-PCOS Women Referring to In Vitro Fertilization Center: Case-Control Study.
International journal of fertility & sterility ·doi:10.22074/ijfs.2024.2015991.1575

BackgroundReproductive dysfunctions of polycystic ovary syndrome (PCOS) and blood anti-mullerian hormone (AMH) concentration are significantly influenced by the dietary advanced glycation end products (AGEs). The interplay between AGEs and …

2023
Serum and follicular fluid levels of soluble receptor for advanced glycation end-products in women with and without polycystic ovary syndrome.
Journal of ovarian research ·doi:10.1186/s13048-023-01224-z

BackgroundAdvanced glycation end products (AGEs) are known to associate with the pathogenesis of several chronic diseases via interaction with their corresponding receptor (RAGE). The soluble forms of RAGE (sRAGE) are considered as anti-inf…